Indivior PLC

General ticker "INDV" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $3.5B (TTM average)

Indivior PLC follows the US Stock Market performance with the rate: 52.3%.

Estimated limits based on current volatility of 1.0%: low 38.12$, high 38.90$

Factors to consider:

  • Total employees count: 838 as of 2025
  • US accounted for 0.3% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [21.37$, 42.60$]
  • 2026-12-31 to 2027-12-31 estimated range: [17.24$, 35.28$]

Financial Metrics affecting the INDV estimates:

  • Positive: with PPE of 14.6 at the end of fiscal year the price was neutral
  • Negative: negative Operating cash flow
  • Positive: Operating profit margin, % of 21.39 > 18.39
  • Negative: Investing cash flow per share per price, % of -1.47 <= -0.60
  • Negative: negative Industry operating cash flow (median)
  • Negative: Shareholder equity ratio, % of -8.16 <= 19.24
  • Positive: Return on assets ratio (scaled to [-100,100]) of 14.88 > 6.06

Similar symbols

Short-term INDV quotes

Long-term INDV plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $854.00MM $1,188.00MM $1,239.00MM
Operating Expenses $1,006.00MM $1,156.00MM $974.00MM
Operating Income $-152.00MM $32.00MM $265.00MM
Non-Operating Income $7.00MM $-18.00MM $-26.00MM
Interest Expense $35.00MM $41.00MM $45.00MM
R&D Expense $116.00MM $107.00MM $97.00MM
Income(Loss) $-145.00MM $14.00MM $239.00MM
Taxes $-19.00MM $11.00MM $29.00MM
Net Income(Loss)* $-126.00MM $2.00MM $210.00MM
Stockholders Equity $-191.00MM $-337.00MM $-98.00MM
Inventory $135.00MM $178.00MM $153.00MM
Assets $1,760.00MM $1,316.00MM $1,201.00MM
Operating Cash Flow $-300.00MM $36.00MM $-27.00MM
Capital expenditure $53.00MM $29.00MM $66.00MM
Investing Cash Flow $-95.00MM $69.00MM $-66.00MM
Financing Cash Flow $-64.00MM $-102.00MM $-30.00MM
Earnings Per Share** $-0.92 $0.02 $1.68

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.